Zhejiang Haisen Pharmaceutical Co Ltd Ordinary Shares - Class A 001367
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 35.05
- Day Range
- CNY 34.83–35.76
- 52-Week Range
- CNY 26.55–59.90
- Bid/Ask
- CNY 35.56 / CNY 35.57
- Market Cap
- CNY 2.42 Bil
- Volume/Avg
- 1.1 Mil / 762,716
Key Statistics
- Price/Earnings (Normalized)
- 21.10
- Price/Sales
- 5.29
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Zhejiang Haisen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and intermediates.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Growth
- Total Number of Employees
- 636
- Website
- http://www.haisenpharma.com
Comparables
Valuation
|
Metric
|
001367
|
301277
|
688506
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.10 | 25.56 | — |
Price/Book Value | 1.99 | 2.54 | 139.09 |
Price/Sales | 5.29 | 5.68 | 94.28 |
Price/Cash Flow | 34.13 | 21.70 | — |
Price/Earnings
001367
301277
688506
Financial Strength
|
Metric
|
001367
|
301277
|
688506
|
|---|---|---|---|
Quick Ratio | — | — | 0.69 |
Current Ratio | — | — | 0.94 |
Interest Coverage | — | — | −21.76 |
Quick Ratio
001367
301277
688506
Profitability
|
Metric
|
001367
|
301277
|
688506
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | −39.67% |
Return on Equity (Normalized) | — | — | −109.79% |
Return on Invested Capital (Normalized) | — | — | −56.17% |
Return on Assets
001367
301277
688506
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Bctgkjhpn | Vgjpq | $697.4 Bil | |
JNJ
| Johnson & Johnson | Gzrttqls | Qlyj | $353.8 Bil | |
MRK
| Merck & Co Inc | Wdynwvvfd | Znfm | $332.3 Bil | |
ABBV
| AbbVie Inc | Vfkpzkqb | Hxgq | $282.6 Bil | |
AZN
| AstraZeneca PLC ADR | Vrzbtjctxl | Qqwz | $232.3 Bil | |
NVS
| Novartis AG ADR | Ygcfzlb | Dfvc | $200.1 Bil | |
RHHBY
| Roche Holding AG ADR | Fmmyltfzv | Mscch | $195.3 Bil | |
AMGN
| Amgen Inc | Frjstwsh | Ndv | $144.5 Bil | |
PFE
| Pfizer Inc | Lzctyxcy | Zdy | $143.8 Bil | |
SNY
| Sanofi SA ADR | Hykymfcn | Ggdb | $122.2 Bil |